Drugs and Therapy Perspectives

期刊基本信息

  • 期刊名称:Drugs and Therapy Perspectives
  • 期刊级别: Scopus (CiteScore)
  • 期刊ISSN:1172-0360
  • 期刊EISSN:1179-1977
  • 实时影响因子:-
  • h-index:暂无h-index数据
  • 2024-2025自引率:N.A.
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/drtp
  • 是否OA开放访问:No
  • 出版商:Springer Nature

Drugs and Therapy Perspectives

Scopus (CiteScore)

期刊介绍

Drugs & Therapy Perspectives promotes rational pharmacotherapy and effective disease management by publishing concise, authoritative review articles to aid drug formulary and treatment decisions, and original research articles covering all aspects of pharmacological treatment to assist healthcare professionals in providing quality patient care. It focuses on the practical application of research and best evidence for healthcare professionals working in real-world clinical settings. TheJournal includes:

Reviews of pharmacological agents, disease management, adverse drug reactions and interactions, or other clinically relevant issues. These provide up-to-date guidance on the use of pharmacological agents in the real-world setting, including step-by-step patient care guidelines to aid treatment decisions, and  the differential features of drugs to enable formulary comparisons.Original research articles with a strong focus on clinical practice and real-world outcomes to assist healthcare professionals in providing quality evidence-based patient care.Therapy-in-practice articles, current opinions and commentaries giving international viewpoints on emerging issues and therapeutic approaches to specific diseases or therapeutic questions.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs & Therapy Perspectives may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to single-blind peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

CITESCORE

CiteScoreSJRSNIPCiteScore排名
1.000.2320.194
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q4214 / 275
22%

WOS期刊JCR分区

WOS分区等级:0区

暂无按学科分区信息

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区1区
PHARMACOLOGY & PHARMACY
药学
4区1区4区

中科院2023年12月旧的升级版

(没有被2023年的JCR升级版收录,仅供参考)

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友